CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

about

Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors.

P2860

Q47243785-4748537A-7F4B-45CE-A519-36EBF5518A9B Q55649893-A9F58304-5898-450C-8CE3-CCAB4EFA7F75

P2860

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

Item

http://www.wikidata.org/entity/Q47924309

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

@en

CSP-1103

@nl

type

Item

label

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

@en

CSP-1103

@nl

prefLabel

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

@en

CSP-1103

@nl

P1476

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects

@en

P2093

Aki Sugano

http://www.w3.org/2001/XMLSchema#string

Ken-Ichi Yamamura

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Lixia Qiang

http://www.w3.org/2001/XMLSchema#string

Shoude Jin

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Sakaeda

http://www.w3.org/2001/XMLSchema#string

Xiangshun Li

http://www.w3.org/2001/XMLSchema#string

Yanshuang Mu

http://www.w3.org/2001/XMLSchema#string

Yanxia Guan

http://www.w3.org/2001/XMLSchema#string

Yutaka Takaoka

http://www.w3.org/2001/XMLSchema#string

P2860

Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Rational design of potent human transthyretin amyloid disease inhibitors

Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action

Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization

Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

Inhibiting transthyretin conformational changes that lead to amyloid fibril formation

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial

P304

42-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13506129.2017.1308348

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bruno Imbimbo

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28393633

http://www.w3.org/2001/XMLSchema#string

P921

human subject research

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

about

P2860

P2860

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921